lbda - ask the expert - dr. james leverenz
TRANSCRIPT
![Page 1: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/1.jpg)
Update on LBD Research: A Focus on Genetics
James B. Leverenz, MDCleveland Lou Ruvo Center for Brain Health
Neurological InstituteCleveland Clinic
![Page 2: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/2.jpg)
Disclosures
Consulting
• Axovant
• GE Healthcare
• Navidea Biopharmaceuticals
• Piramal Healthcare
• Teva
Grant Support
• Axovant
• Genezyme/Sanofi
• Lundbeck
![Page 3: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/3.jpg)
Overview
Definitions
Genetics 101
Genetics of Lewy Body Dementia (LBD)
• Cognition in Parkinson’s disease (PD)
• Dementia with Lewy Bodies (DLB)
![Page 4: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/4.jpg)
What is a Lewy body?
![Page 5: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/5.jpg)
Alpha-Synuclein in Lewy Bodies
a-synuclein immunohistochemistry
![Page 6: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/6.jpg)
Neuropathology of Community Based Dementia
![Page 7: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/7.jpg)
Normal
(n=2)
HS+Vasc
(n=5)
HS+DLB
(n=2)HS
(n=10)HS+AD+Vasc
(n=1)
Vasc
(n=20)
PSP
(n=4)
Other
(n=12)
AD
(n=37)
AD+Vasc
(n=33)
DLB
(n=15)AD+Other
(n=1)
AD/DLB
(n=52)
DLB+Vasc
(n=17)
AD/DLB+Vasc
(n=31)
AD/DLB+Other
(n=1)
HS+AD/DLB
(n=5)
7%
21%
13%
2%
15%
8%
4%
5%
2%
13%
6%
Neuropathology of Community Based Dementia
![Page 8: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/8.jpg)
Dementia
McKhann et al., Alzheimer’s & Dementia, 1-7, 2011.
NIA/AA: “Dementia is diagnosed when there is
A change in at least two cognitive domains:
Memory
Executive function
Visuospatial
Language
Behavior
A decline from previous levels of functioning
A decline in the ability to function at work or at usual
activities
![Page 9: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/9.jpg)
The Lewy Body Dementias
Parkinson’s Disease Dementia
Dementia with Lewy Bodies
![Page 10: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/10.jpg)
Emre M, et al. Mov Disord, 22:1689-1707, 2007
CLINICAL DIAGNOSIS OF PD DEMENTIA
2007 Clinical Diagnostic Criteria
Diagnosis of PD
Dementia syndrome within the context of
established PD
impairment in more than one cognitive domain
decline from premorbid level
deficits severe enough to impair daily life
![Page 11: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/11.jpg)
McKeith et al, Neurology 65:1863-72, 2005.
Consensus Criteria for Dementia with Lewy Bodies
1. Progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational function…
2. Core features (2 = “probable”, 1 = “possible”)
• a. fluctuating cognition, attention, alertness
• b. recurrent visual hallucinations
• c. spontaneous features of parkinsonism
3. Suggestive features (plus one core = “probable” DLB)
• a. REM sleep behavior disorder
• b. severe neuroleptic sensitivity
• c. low dopamine transporter uptake (PET/SPECT)
4. One year rule for PDD vs. DLB
![Page 12: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/12.jpg)
Common clinical symptoms
Parkinsonism
Visual hallucinations
Fluctuations
REM Sleep Disorder
Is it all timing?
For criteria, yes
Just a variant of same disease?
PDD vs.DLB
![Page 13: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/13.jpg)
Genetics 101
![Page 14: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/14.jpg)
Human Chromosomes
![Page 15: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/15.jpg)
Human Chromosomes
![Page 16: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/16.jpg)
Inheritance Patterns
![Page 17: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/17.jpg)
The Complexity of Genetics
![Page 18: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/18.jpg)
The Complexity of Genetics
Most genetics are related to RISK
APOE e4 in Alzheimer’s disease
Increased riskCan have two
copies and never get AD
Can get AD without
carrying this gene
We carry gene “variants” that increase or decrease our risk
Likely it’s the combination that
determines disease
![Page 19: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/19.jpg)
Genetics of LBD
![Page 20: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/20.jpg)
Common clinical symptoms
Parkinsonism
Visual hallucinations
Fluctuations
REM Sleep Disorder
Is it all timing?
For criteria, yes
Just a variant of same disease?
PDD vs.DLB
![Page 21: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/21.jpg)
Neuropathology of Community Based Dementia
![Page 22: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/22.jpg)
Lewy Body Pathology in Alzheimer’s Disease
Leverenz et al, Arch Neurol, 2006
![Page 23: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/23.jpg)
DLB, PDD and
Alzheimer’s Disease
Is DLB just a variant of
PD/PDD?Is DLB just a variant of
AD?
![Page 24: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/24.jpg)
AD LBD-AD
DLB
PD & PD-D
![Page 25: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/25.jpg)
Genetics of the LBDs
Tsuang, JAMA Neurol, 2013
![Page 26: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/26.jpg)
APOE e4 and the LBDs
Tsuang et al, JAMA Neurol, 2013
![Page 27: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/27.jpg)
Bras et al, Hum Mol Genet, 2014
APOE e4 and the LBDs
![Page 28: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/28.jpg)
Bras et al, Hum Mol Genet, 2014
APOE e4 and the LBDs
Bras et al
APOE finding just an association with Ab deposition?• Why are other AD genes not associated?
![Page 29: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/29.jpg)
Bras et al, Hum Mol Genet, 2014
APOE e4 and the LBDs
• 140 autopsied cases
• Links to dementia
» Lewy pathology
» APOE e4
» AD (~ 30%)
![Page 30: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/30.jpg)
Genetics of PD
Risk FactorSmall Effect
Risk FactorLarge Effect
Pathogenic Mutation
(reduced penetrance)
Pathogenic Mutation
(complete penetrance)
Risk
<───── 6 Causal Genes ─────><─── 20+ Susceptibility Genes ── ─>
LRRK2(G2019S)
LRRK2(R1441C)
SNCA(A53T)
PARK2
SNCA(SNPs)
MAPT
LRRK2(SNPs)
GBA(N370S)
HIP1R
HLA
BST1
RAB25
![Page 31: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/31.jpg)
Genetics of the LBDs
Glucocerebrosidase (GBA)o Homozygotes associates with Gaucher’s diseaseo Clear link to PD risk in heterozygoteso ~ 7x increase risk in carriers
![Page 32: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/32.jpg)
Genetics of the LBDs
Tsuang et al, Neurology, 79:1944-50, 2012
![Page 33: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/33.jpg)
DLB, PDD and Alzheimer’s Disease
Is DLB just a variant of PD/PDD?
• Similar Lewy body pathology
• Some shared genetics (e.g., GBA)
Is DLB just a variant of AD?
• Frequent AD pathology in DLB
• Some shared genetics (e.g., APOE)
![Page 34: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/34.jpg)
AD LBD-AD
DLB
PD & PD-D
![Page 35: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/35.jpg)
AD LBD-AD
DLB
PD & PD-D
![Page 36: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/36.jpg)
Seattle:–Pinky Agarwal, MD
–Lynn Bekris, PhD
–Daniel Burdick, MD
–Marie Davis, MD, PhD
–Karen Edwards, PhD
–Brooke Gerton, MD
–Alida Griffith, MD
–Gene Hu, MD, PhD
–Mike Kim, MD
–Katelan Longfellow, MD
–Erica Martinez
–Ignacio Mata, PhD
–Tom Montine, MD, PhD
–John Roberts, MD
–Debby Tsuang, MD, MS
–G. Stennis Watson, PhD
–Dora Yearout
–Jia Yin, MS
– Cyrus Zabetian, MD, MSc
Emory University–Stewart Factor, DO
–Julia Land, PsyD
Johns Hopkins University–Liana Rosenthal, MD
–Ted Dawson, MD, PhD
–Marilyn Albert, PhD
Mayo Clinic, FL–Zbigniew K. Wszolek, MD
–Ryan Uitti, MD
–Dennis Dickson, MD
OHSU-PVAMC–Joe Quinn, MD
–Kathy Chung, MD
–John Nutt, MD
–Susan O'Connor
Rush University–Jennifer Goldman, MD
–Glenn Stebbins, PhD
–Bryan Bernard, PhD
UCLA–Beate Ritz, MD, PhD
–Rebecca Rausch, PhD
University of Cincinnati –Alberto Espay, MD
–Fredy Revilla, MD
–Johnna Devoto, PhD
University of Pennsylvania–Daniel Weintraub, MD
–John Trojanowski, MD, PhD
–Howard Hurtig, MD
–Alice Chen-Plotkin, MD
–Vivianna Van Deerlin, MD, PhD
![Page 37: LBDA - Ask the Expert - Dr. James Leverenz](https://reader034.vdocuments.site/reader034/viewer/2022051405/589c6a191a28abe96c8b511d/html5/thumbnails/37.jpg)
AD LBD-AD
DLB
PD & PD-D
Questions?